22 December 2021>: Original Paper
Comparison of Coronary Artery Calcium Scoring with Dobutamine Stress Echo for Detection of Coronary Artery Disease Before Liver Transplantation
Cerise Kleb 1ABDEF , Vardhmaan Jain 1CE , Chirag Sheth 2ABD , Kathy Wolski 3CE , Samir Kapadia 3EG , Richard Grimm 3AB , Milind Desai 3A , Amar Krishnaswamy 3A , Nicholas Kassis 1E , Calvin Sheng 3E , Huili Zheng 4C , Jacek Cywinski 5A , K.V. Narayanan Menon 6A , Bijan Eghtesad 6A , Teresa Diago Uso 6A , Cristiano Quintini 6A , Paul Schoenhagen 7AD , Serge C. Harb 3A , Vikram Sharma 8ACDEF* , Maan Fares 3ADEG**DOI: 10.12659/AOT.934163
Ann Transplant 2021; 26:e934163
Table 1 Baseline characteristics of patients.
All patients (n=265) | DSE (n=173) | CACS (n=133) | |
---|---|---|---|
Average age at transplant (years) (±standard deviation) | 60.1±7.1 | 60.4±6.3 | 60.4±6.8 |
Gender | Male: 61.5% | Male: 60.1% | Male: 59.7% |
Female: 27.5% | Female: 26.0% | Female: 26.9% | |
Unknown: 10.9% | Unknown: 13.9% | Unknown: 13.4% | |
Race | White: 73.9% | White: 71.7% | White: 68.7% |
African American: 5.3% | African American: 5.2% | African American: 6.7% | |
Hispanic: 3.4% | Hispanic: 3.5% | Hispanic: 3.0% | |
Asian: 0.4% | Asian: 0.0% | Asian: 0.8% | |
Other: 6% | Other: 5.8% | Other: 8.2% | |
Unknown: 10.9% | Unknown: 13.9% | Unknown: 13.4% | |
Hypertension | Yes: 66.4% | Yes: 64.2% | Yes: 70.1% |
No: 22.6% | No: 22.0% | No: 16.4% | |
Unknown: 11.0% | Unknown: 13.8% | Unknown: 13.5% | |
Hyperlipidemia | Yes: 37.0% | Yes: 36.4% | Yes: 37.3% |
No: 52.1% | No: 49.7% | No: 49.3% | |
Unknown: 10.9% | Unknown: 13.9% | Unknown: 13.4% | |
Obesity | Yes: 23.0% | Yes: 23.1% | Yes: 28.9% |
No: 66.0% | No: 63.0% | No: 59.7% | |
Unknown: 11.0% | Unknown: 13.9% | Unknown: 11.4% | |
Average MELD Score (±standard deviation) | 21.5±9.5 | 21±9.6 | 22.1±9.6 |
Indication for OLT | ASH cirrhosis: 16.6% | ASH cirrhosis: 19.7% | ASH cirrhosis: 21.6% |
NASH cirrhosis: 17.0% | NASH cirrhosis: 19.1% | NASH cirrhosis: 18.7% | |
HCV/HBV Cirrhosis: 10.2% | HCV/HBV cirrhosis: 15.6% | HCV/HBV cirrhosis: 14.9% | |
PSC/PBC: 7.9% | PSC/PBC: 11.0% | PSC/PBC: 7.5% | |
AH: 1.1% | AH: 0.6% | AH: 0.0% | |
HCC: 3.4% | HCC: 3.5% | HCC: 3.7% | |
Other: 29.1% | Other: 24.3% | Other: 30.0% | |
Unknown: 14.7% | Unknown: 6.2% | Unknown: 3.6% | |
AH – autoimmune hepatitis; ASH – alcoholic steatohepatitis; HBV – hepatitis B virus; HCC – hepatocellular carcinoma; HCV – hepatitis C virus; NASH – non-alcoholic steatohepatitis; PBC – primary biliary cirrhosis; PSC – primary sclerosing cholangitis. |